Clonal haematopoiesis and atherosclerosis: a chicken or egg question?
Authors:
- 15 April 2021
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 18 (7) , 463-464
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection FractionJACC, 2021
- The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesisNature, 2021
- Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesisCell, 2021
- Inherited causes of clonal haematopoiesis in 97,691 whole genomesNature, 2020
- Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal HematopoiesisCirculation, 2020
- Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart FailureJAMA Cardiology, 2019
- Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 InflammasomeJACC, 2018
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in miceScience, 2017
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014